Hospira, FDA Friday, September 13, 1985 0.00 Neutral

FDA Approves LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE — Hospira, Inc.

# FDA Approves Lidocaine Hydrochloride and Epinephrine for Epidural Use Hospira, Inc. has received FDA approval for lidocaine hydrochloride and epinephrine as an epidural anesthetic, expanding the company's portfolio in the regional anesthesia market and strengthening its competitive position in surgical pain management solutions. The approval positions Hospira to capture a share of the growing demand for effective epidural anesthetics in hospital and surgical center settings.

View original filing at SEC.gov →
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.

Get real-time financial news in your trading bot or app

GET FREE KEY — 10,000 calls/day